Sbir PH III 17-0001A topic A14-045 modernized production adenovirus vaccine (mpav), DPA title III, pre-objective 1

Ended Definitive Contract Awarded Last action

Contract number
W81XWH18C0351
Awardee
Awarding agency
Obligated
$652,166

Award facts

Opportunity
  • HQ003414RMMDA Solicitation number
Contract value 100% obligated
$652,166.39 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost No Fee
Place of performance
Redwood City, CA 94065, USA
Research
SBIR Program Phase III Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Funding Only Action P00004 $208,282
Other Administrative Action P00003 · Sbir phase III medical r & d contract for proposal #17-0001A, titled: modernized production adenovirus vaccine (mpav) - disposition of government furnished… $0
Vendor DUNS or Name Change - Non-Novation P00002 · Army 2014 sbir phase III medical r & d contract for proposal #17-0001A, titled: "modernized production adenovirus vaccine (mpav)", DPA title III,… $0
Supplemental Agreement for work within scope P00001 · Army 14.1 sbir phase III medical r & d contract for proposal titled: "modernized production adenovirus vaccine (mpav)" - pre-objective costs - addition of GFP $0
Original award $443,885

About this award

This federal contract award is for SBIR Phase III research under Topic A14-045 "Modernized Production Adenovirus Vaccine (MPAV)" for the Department of the Army Medical Command. The prime contractor is Emergent Travel Health Inc., a for-profit biopharmaceutical company that specializes in vaccine development and production. The contract is a definitive, cost-no-fee contract with a potential value of $652,166.39. The work is being performed at Emergent's facility in Redwood City, California. Emergent has previously provided vaccine-related goods and services to various federal agencies, including the NIH, FBI, and VA. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract W81XWH18C0351?

W81XWH18C0351 was awarded to Emergent Travel Health Inc. by Medical Command (Department of the Army) on April 6, 2018.

How much is contract W81XWH18C0351 worth?

The government has obligated $652,166 on W81XWH18C0351.

Was contract W81XWH18C0351 competed?

The extent of competition for W81XWH18C0351 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award